GlassScriptPhysician profile
Louis Gilbert
NPI 1285051599
$3,291.97
in general payments reported to CMS, 2019-2025
21 companies · $325 in 2025
The $325 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $766 · 2021: $1,095 · 2022: $147 · 2023: $461 · 2024: $348 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,134.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $877.90 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Pfizer INC. | $384.89 | 2020-2024 | |
| Astrazeneca Pharmaceuticals LP | $379.02 | 2020-2025 | Airsupra |
| Abbvie INC. | $362.44 | 2021-2025 | |
| Lilly USA, LLC | $217.30 | 2019-2025 | Zepbound |
| Abbott Laboratories | $206.55 | 2023-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $155.96 | 2020-2023 | Arexvy |
| Mylan Specialty L.P. | $149.85 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.57 | 2021-2023 | Jardiance |
| Eisai INC. | $76.96 | 2020-2021 | |
| Amgen INC. | $75.71 | 2021-2025 | Repatha, Repatha, Otezla |
| Allergan, INC. | $68.83 | 2020 | |
| Astellas Pharma US INC | $57.63 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $55.25 | 2021-2023 | Xifaxan, Trulance |
| Inspire Medical Systems, INC. | $28.50 | 2025 | Inspire |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $27.56 | 2025 | Trintellix |
| Janssen Pharmaceuticals, INC | $20.22 | 2021 | |
| Exact Sciences Corporation | $17.59 | 2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $16.07 | 2019 | |
| Ethicon US, LLC | $14.14 | 2021 | |
| Idorsia Pharmaceuticals US INC | $14.03 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Louis Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.